What is the Future of Multiplexed Precision Therapy Including Trogocytosed Immune Cells?
Time: 2:30 pm
day: Day One Track A PM
Details:
• How the evaluation of minimal residual disease may influence a medical decision in hematological malignancies?
• Place of trogocytosed NK in the diagnosis and follow-up of rare malignant lymphomas
